These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2424218)

  • 41. The role of complement-derived mediators in inflammatory skin diseases.
    Tagami H
    Arch Dermatol Res; 1992; 284 Suppl 1():S2-9. PubMed ID: 1285651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
    Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
    J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
    Brain S; Camp R; Dowd P; Black AK; Greaves M
    J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics.
    Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ
    Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin.
    Schröder JM; Christophers E
    J Invest Dermatol; 1985 Sep; 85(3):194-8. PubMed ID: 3161955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-molecular-weight leukocyte chemotactic factors in psoriatic scales: contribution of lipid-soluble factors to the chemotactic activity.
    Takematsu H; Kato T; Tagami H
    J Dermatol; 1988 Aug; 15(4):287-93. PubMed ID: 2848878
    [No Abstract]   [Full Text] [Related]  

  • 47. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    Ruzicka T; Simmet T; Peskar BA; Ring J
    J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eosinophilic pustular folliculitis. Studies on possible chemotactic factors involved in the formation of pustules.
    Takematsu H; Tagami H
    Br J Dermatol; 1986 Feb; 114(2):209-15. PubMed ID: 3511943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion of carotene to vitamin A by sebaceous glands; interference in pityriasis rubra pilaris, ichthyosis, and psoriasis as shown by fluorescent microscopy.
    CORNBLEET T; GREENBERG R
    AMA Arch Derm; 1957 Oct; 76(4):431-3. PubMed ID: 13457425
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of malignant ascites and pleurisy by a streptococcal preparation OK-432 with fresh frozen plasma--a mechanism of polymorphonuclear leukocyte (PMN) accumulation.
    Kato H; Yamamura Y; Kin R; Tanigawa M; Sano H; Inoue M; Sugino S; Kondo M
    Int J Immunopharmacol; 1989; 11(2):117-28. PubMed ID: 2539336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotactic lipoxygenase products in sera from patients with psoriasis.
    Fogh K; Ternowitz T; Kragballe K; Herlin T
    Arch Dermatol Res; 1986; 278(3):173-6. PubMed ID: 3015047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pustular psoriasis and aseptic purulent arthritis: possible role of leukotrienes B4 and C4 in a flare of synovitis.
    Kawana S; Nishiyama S
    Dermatology; 1995; 190(1):35-8. PubMed ID: 7894093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.
    Schröder JM; Christophers E
    J Invest Dermatol; 1986 Jul; 87(1):53-8. PubMed ID: 3014008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales.
    Bergh K; Iversen OJ; Lysvand H
    Arch Dermatol Res; 1993; 285(3):131-4. PubMed ID: 8503693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concentrations of leukotriene B4 in symptomatic and asymptomatic periapical lesions.
    Torabinejad M; Cotti E; Jung T
    J Endod; 1992 May; 18(5):205-8. PubMed ID: 1328456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential amino acids and disease processes. I. Psoriasis and pityriasis rubra pilaris.
    ROWE L
    Arch Dermatol; 1960 Mar; 81():405-14. PubMed ID: 14439688
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP.
    Christophers E; Schröder JM; Mrowietz U
    Dermatologica; 1989; 179 Suppl 1():9-15. PubMed ID: 2673857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotactic factor generation and cell accumulation in acute lung injury induced by endotracheal acid instillation.
    Ishii Y; Kobayashi J; Kitamura S
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):65-70. PubMed ID: 2548220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of complement by 405-nm light in serum from porphyria cutanea tarda.
    Torinuki W; Miura T; Tagami H
    Arch Dermatol Res; 1985; 277(3):174-8. PubMed ID: 4015182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.